WallStreetZenWallStreetZen

NASDAQ: HARP
Harpoon Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

HARP past revenue growth

How has HARP's revenue growth performed historically?
Company
68.31%
Industry
70.34%
Market
14.07%
HARP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HARP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HARP's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HARP earnings and revenue history

Current Revenue
$34.6M
Current Earnings
-$58.7M
Current Profit Margin
-169.8%

HARP Return on Equity

Current Company
-473.1%
Current Industry
-18%
Current Market
30.8%
HARP's Return on Equity (-473.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HARP announces earnings.

HARP Return on Assets

Current Company
-67.7%
Current Industry
0.9%
HARP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HARP Return on Capital Employed

Current Company
-159.98%
Current Industry
14.1%
HARP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HARP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HARP$34.59M-$55.17M-$58.75M+68.91%N/A
KA$1.21M-$56.64M-$56.48M-25.45%N/A
UNCY$0.00-$28.91M-$29.29MN/AN/A
MTEM$47.90M-$47.64M-$60.26M+88.89%N/A
RGLS$0.00-$27.88M-$28.74M-100.00%N/A
View Top Biotech Stocks

HARP earnings dates

Next earnings date
Aug 8, 2023

Harpoon Therapeutics Earnings & Revenue FAQ

What were HARP's earnings last quarter?

On Invalid Date, Harpoon Therapeutics (NASDAQ: HARP) reported Q1 2023 earnings per share (EPS) of -$0.31, up 50% year over year. Total Harpoon Therapeutics earnings for the quarter were -$11.34 million. In the same quarter last year, Harpoon Therapeutics's earnings per share (EPS) was -$0.62.

If you're new to stock investing, here's how to buy Harpoon Therapeutics stock.

What was HARP's earnings growth in the past year?

As of Q2 2023, Harpoon Therapeutics's earnings has grown year over year. Harpoon Therapeutics's earnings in the past year totalled -$58.75 million.

What is HARP's earnings date?

Harpoon Therapeutics's earnings date is Invalid Date. Add HARP to your watchlist to be reminded of HARP's next earnings announcement.

What was HARP's revenue last quarter?

On Invalid Date, Harpoon Therapeutics (NASDAQ: HARP) reported Q1 2023 revenue of $8.58 million up 45.33% year over year. In the same quarter last year, Harpoon Therapeutics's revenue was $5.91 million.

What was HARP's revenue growth in the past year?

As of Q2 2023, Harpoon Therapeutics's revenue has grown 68.31% year over year. This is 2.04 percentage points lower than the US Biotechnology industry revenue growth rate of 70.34%. Harpoon Therapeutics's revenue in the past year totalled $34.59 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.